For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240308:nRSH0665Ga&default-theme=true
RNS Number : 0665G Primary Health Properties PLC 08 March 2024
Primary Health Properties PLC
Director's & PDMR dealings
On 5 March 2024, the remuneration committee of Primary Health Properties PLC
(the "Company" or "PHP") made the following awards of nil-cost options under
the Company's 2021 Long-term Incentive Plan ("LTIP") to a Director and Persons
Discharging Managerial Responsibilities ("PDMR's").
Director Number of shares under option
Richard Howell 539,779
PDMR
David Bateman 348,137
Toby Newman 115,488
David Austin 131,109
The number of nil-cost options were calculated by reference to a price of
£0.8962, being the average of the closing middle market quotations for the
Company's ordinary shares on 28 February 2024, 29 February 2024 and 1 March
2024.
The nil-cost options will normally vest on the third anniversary of grant,
subject to the attainment of performance conditions. The remuneration
committee has the discretion to adjust the awards downwards at vesting for
malus reasons. Details of the operation of the LTIP are set out in the
Company's 2022 Report and Accounts.
Details of the transactions referenced above are included below in accordance
with the under Article 19 of the retained EU law version of the Market Abuse
Regulation (Regulation 596/2014).
1 Details of the person discharging managerial responsibilities/person closely
associated
(a) Name Richard Howell
2 Reason for notification
(a) Position/Status Chief Financial Officer
(b) Initial notification/amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
(a) Name Primary Health Properties PLC
(b) LEI 213800Y5CJHXOATK7X11
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date: and (iv) each
place where transactions have been conducted
(a) Description of the financial instrument, type of instrument and identification Ordinary shares of 12.5p
code
ISIN: GB00BYRJ5J14
(b) Nature of transaction Award of nil-cost options over the Company's ordinary shares
(c) Price(s) and volume(s) Price(s) Volume(s)
Nil cost 539,779
(d) Aggregated Information Single transaction: N/A
(e) Date of transaction 7 March 2024
(f) Place of transaction N/A
1 Details of the person discharging managerial responsibilities/person closely
associated
(a) Name David Bateman
2 Reason for notification
(a) Position/Status PDMR
(b) Initial notification/amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
(a) Name Primary Health Properties PLC
(b) LEI 213800Y5CJHXOATK7X11
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date: and (iv) each
place where transactions have been conducted
(a) Description of the financial instrument, type of instrument and identification Ordinary shares of 12.5p
code
ISIN: GB00BYRJ5J14
(b) Nature of transaction Award of nil-cost options over the Company's ordinary shares
(c) Price(s) and volume(s) Price(s) Volume(s)
Nil cost 348,137
(d) Aggregated Information Single transaction: N/A
(e) Date of transaction 7 March 2024
(f) Place of transaction N/A
1 Details of the person discharging managerial responsibility/person closely
associated
(a) Name Toby Newman
2 Reason for notification
(a) Position/Status Company Secretary & Chief Legal Officer
(b) Initial notification/amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
(a) Name Primary Health Properties PLC
(b) LEI 213800Y5CJHXOATK7X11
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date: and (iv) each
place where transactions have been conducted
(a) Description of the financial instrument, type of instrument and identification Ordinary shares of 12.5p
code
ISIN: GB00BYRJ5J14
(b) Nature of transaction Award of nil-cost options over the Company's ordinary shares
(c) Price(s) and volume(s) Price(s) Volume(s)
Nil cost 115,488
(d) Aggregated Information Single transaction: N/A
(e) Date of transaction 7 March 2024
(f) Place of transaction N/A
1 Details of the person discharging managerial responsibilities/person closely
associated
(a) Name David Austin
2 Reason for notification
(a) Position/Status PDMR
(b) Initial notification/amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
(a) Name Primary Health Properties PLC
(b) LEI 213800Y5CJHXOATK7X11
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date: and (iv) each
place where transactions have been conducted
(a) Description of the financial instrument, type of instrument and identification Ordinary shares of 12.5p
code
ISIN: GB00BYRJ5J14
(b) Nature of transaction Award of nil-cost options over the Company's ordinary shares
(c) Price(s) and volume(s) Price(s) Volume(s)
Nil cost 131,109
(d) Aggregated Information Single transaction: N/A
(e) Date of transaction 7 March 2024
(f) Place of transaction N/A
More information on Primary Health Properties PLC can be found on
www.phpgroup.co.uk (//www.phpgroup.co.uk)
Further details:
Harry Hyman Steven Owen
Chief Executive Officer Chairman
Tel: +44 (0) 7973 344768 Tel: +44 (0) 203 8241 841
Richard Howell
Chief Financial Officer
Tel: +44 (0) 7766 072272
David Rydell / Stephanie Whitmore (Buchanan Communications)
Tel: +44 (0) 20 7466 5066
Legal Entity Identifier: 213800Y5CJHXOATK7X11
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHBRGDXGDGDGSR